Home Start
Lecture
Presentation
Download
Podcast
Enter
Learning Assessment
& Evaluation
Download
Activity
Workbook

OVERVIEW
This free CE activity consists of a presentation, a learning assessment, and an evaluation. This virtual lecture is derived from a satellite symposium presented on May 3, 2014, in conjunction with the Oncology Nursing Society 39th Annual Congress in Anaheim, CA.

MEDIUM: Virtual Lecture
INTERNET RELEASE DATE: August 1, 2014

(Continuing education credit is no longer available for this activity.)

Estimated time to complete this activity: 1.5 hours


TARGET AUDIENCE
This activity has been designed to meet the education needs of nurses and social workers involved in the care of patients living with hematologic cancers.


PROGRAM GOAL
This activity will provide an opportunity for nurses and social workers to expand their knowledge about how clinical trials and genomics influence treatment and prognosis for patients with blood cancers.


PROGRAM OVERVIEW
Clinical trials are important in advancing treatment options for patients with blood cancers. Oncology nurses and social workers are key players in clinical trials, including identifying, implementing, educating, treating, monitoring and navigating patients throughout their cancer experience. Personalized nurse-patient communication can contribute to patient enrollment and promote optimal outcomes related to their treatment.

The rapidly evolving and expanding field of genomics is influencing oncology care. Nurses and social workers need to understand the practical applications of this emerging science, including prognosis, caring for patients, and other critical clinical issues.

The significant role of patient-nurse communication related to testing, treatment, prognosis, ethical issues, diversity, clinical trials, as well as other challenges will be discussed. Through a better understanding of clinical trials and of the role of genomics research in treating patients with blood cancers, nurses and social workers will build knowledge to impact and improve patient care.


EDUCATION OBJECTIVES
After completing this activity, participants should be able to:

  • Explain their role in helping patients to enroll in clinical trials and optimize outcomes
  • Describe how diversity issues impact enrollment and education about clinical trials
  • Identify communication touch points in treating patients in clinical trials
  • Explain how genomics research, including cytogenetics and other biomarkers, relates to treatment and prognosis for patients with blood cancer
  • Describe communication strategies in educating patients about genomic information
  • Describe strategies for addressing ethical issues encountered in patient care

METHOD OF PARTICIPATION
To complete this activity and receive a statement of credit, participants must:

  1. Review all contents of this activity
  2. Complete and submit the learning assessment and evaluation form
  3. Score at least 70% on the learning assessment

CONTINUING EDUCATION INFORMATION FOR NURSES AND SOCIAL WORKERS
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 1.5 continuing education contact hours through the California Board of Registered Nursing.

The Leukemia & Lymphoma Society (LLS), provider number 1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org Approved Continuing Education Program (ACE). Approval Period: December 2011 – December 2014. LLS maintains responsibility for the program. Social workers should contact their regulatory board to determine course approval. Social workers will receive 1.5 CE clinical clock hours.

For questions, grievances, assistance for people with disabilities or more information on LLS programs, please contact an LLS Information Specialist at (800) 955-4572.

Upon successful completion of the entire program, learning assessment (grade of 70% or higher) and submission of the activity evaluation, a certificate of completion will be issued to you within 30 days, via email or US mail based on your designation on the evaluation.


SUPPORT STATEMENT
This program is supported by The Leukemia & Lymphoma Society.


FACULTY
Amy Goodrich, ACNP-BC
Nurse Practitioner
Johns Hopkins Kimmel Cancer Center
Baltimore, MD

Donelle Rizzuto, RN, OCN
Clinical Nurse Coordinator
Seattle Cancer Care Alliance
Seattle, WA


FEE INFORMATION
There is no fee for this educational activity.


QUESTIONS AND TECHNICAL ASSISTANCE
For questions regarding the content of this activity, please contact an LLS Information Specialist at
800-955-4572, or infocenter@lls.org. For technical assistance, contact jungsen@rmcom.net.


SYSTEM REQUIREMENTS
Hardware/Software requirements include:
• Windows XP, 2000, 7, 8   
  - Internet Explorer 4.0+
  - Netscape Navigator 6.2+
  - Mozilla Firefox 1.0+

• Macintosh 9.2, OS X 10.1+
  - Safari 1.1+
  - Netscape Navigator 6.2+
  - Internet Explorer 5.2+
  - Mozilla Firefox 1.0+

• Additional Requirements
  - Adobe Flash Player 7.0+
  - Adobe Reader 7.0+
  - Internal/external speakers
  - Broadband connection (DSL/cable) recommended

 

RMEI Privacy Statement